Brown & Brown built its reputation on being the group that could out-integrate anyone in insurance distribution, over 700 acquisitions since 1993 without losing the culture that made the deals work. That reputation faces its real test now. The company closed its largest acquisition ever, the $9.825 billion purchase of Risk Strategies and One80 Intermediaries, on schedule and is delivering synergies on schedule too, $30 million to $40 million in 2026 against a $150 million target by 2028. What is not on schedule is growth. Core organic revenue fell 2.8% in the fourth quarter of 2025, was flat in the first quarter of 2026, and fell 0.7% in the second quarter. Management has started pointing analysts toward a supplementary metric, organic revenue with contingents, which shows growth in both recent quarters. Whether that is a fuller picture of the business or a reframe of a number that stopped cooperating is not yet answered by the filings.

One thing worth flagging: our Dossier surfaces a governance signal that company commentary has not addressed directly. A member of the founding family stepped down as President of the Retail segment and began a personal leave of absence eleven weeks after the acquisition closed, with no stated reason disclosed. Read one way, that is an unrelated personal matter with no bearing on strategy. Read another way, it is a departure from the family that holds a 12.6% equity stake, during the company's most complex integration to date, at exactly the moment operational bandwidth matters most. The Dossier lays out both readings and does not force a conclusion the record does not support.

Sources and Methods

Each Dossier is built from primary documents: SEC filings and statutory financials, earnings call and investor day transcripts, management presentations, rating agency and regulatory records, company press releases, and trade press. We also work the channels where operating problems surface before they reach an earnings call, including expert interviews with market participants, agent and broker forums, and practitioner communities. Equity analyst commentary is used to map where the sell-side disagrees and is treated as opinion rather than evidence.

The Intelligence Council is editorially independent. No company reviews a Dossier before publication.